212 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
by higher S&M expenses.
Europe Segment
Our Europe segment includes the European Union, the United Kingdom and certain other European countries
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
31 Jan 24
Results of Operations and Financial Condition
7:00am
expenses.
Europe Segment
Our Europe segment includes the European Union, the United Kingdom and certain other European countries.
The following
8-K
EX-99.1
kdam8zqpzxb78b8jy6q3
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-99.1
93xvfr
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
7gyelfh1r8ap241
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
ftco5np3r7uqzfo3rp3
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
15glptuqkih3ra
26 Jul 22
Key financial highlights and outlook
4:56pm
8-K
EX-99.1
v7matnna hds72wq
3 May 22
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
m7k20by zn
9 Feb 22
Results of Operations and Financial Condition
7:00am
8-K
EX-4.2
6k1zu4ps
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm